Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

88 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Promising Step Forward With Giant Leaps Ahead.
Shaverdian N, Li BT, Isbell J, Chaft JE. Shaverdian N, et al. J Thorac Oncol. 2024 Oct;19(10):1370-1372. doi: 10.1016/j.jtho.2024.08.002. J Thorac Oncol. 2024. PMID: 39370218 No abstract available.
Real-world Decision-making Process for Stereotactic Body Radiotherapy Versus Minimally Invasive Surgery in Early-stage Lung Cancer Patients.
Vanstraelen S, Tan KS, Adusumilli PS, Bains MS, Bott MJ, Downey RJ, Gomez DR, Gray KD, Huang J, Isbell JM, Molena D, Park BJ, Rimner A, Rusch VW, Shaverdian N, Sihag S, Wu AJ, Jones DR, Rocco G. Vanstraelen S, et al. Among authors: shaverdian n. Ann Surg. 2024 Oct 1. doi: 10.1097/SLA.0000000000006552. Online ahead of print. Ann Surg. 2024. PMID: 39351678
An 18F-FDG PET/CT and Mean Lung Dose Model to Predict Early Radiation Pneumonitis in Stage III Non-Small Cell Lung Cancer Patients Treated with Chemoradiation and Immunotherapy.
Thor M, Lee C, Sun L, Patel P, Apte A, Grkovski M, Shepherd AF, Gelblum DY, Wu AJ, Simone CB 2nd, Chaft JE, Rimner A, Gomez DR, Deasy JO, Shaverdian N. Thor M, et al. Among authors: shaverdian n. J Nucl Med. 2024 Apr 1;65(4):520-526. doi: 10.2967/jnumed.123.266965. J Nucl Med. 2024. PMID: 38485270 Free PMC article.
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.
Moore A, Zhang Z, Fei T, Zhang L, Accomando L, Schmitt AM, Higginson DS, Mueller BA, Zinovoy M, Gelblum DY, Yerramilli D, Xu AJ, Brennan VS, Guttmann DM, Grossman CE, Dover LL, Shaverdian N, Pike LRG, Cuaron JJ, Dreyfuss A, Lis E, Barzilai O, Bilsky MH, Yamada Y. Moore A, et al. Among authors: shaverdian n. Neurosurgery. 2024 Aug 1;95(2):380-391. doi: 10.1227/neu.0000000000002889. Epub 2024 Mar 8. Neurosurgery. 2024. PMID: 38456696
Response letter to "Stereotactic body radiation therapy for pleural mesothelioma: Which goal, which patients".
Shin JY, Offin M, Simone CB 2nd, Shepherd AF, Wu AJ, Shaverdian N, Gelblum DY, Gomez DR, Sauter JL, Ginsberg MS, Adusumilli PS, Rusch VW, Zauderer MG, Rimner A. Shin JY, et al. Among authors: shaverdian n. Radiother Oncol. 2024 Apr;193:110138. doi: 10.1016/j.radonc.2024.110138. Epub 2024 Feb 10. Radiother Oncol. 2024. PMID: 38342346 No abstract available.
Clinical and Dosimetric Risk Factors Associated With Radiation-Induced Lung Toxicities After Multiple Courses of Lung Stereotactic Body Radiation Therapy.
Li X, Yorke E, Jackson A, Yue Y, Simone CB 2nd, Apte AP, Rimner A, Gomez DR, Shaverdian N, Gelblum DY, Wu AJ, Shepherd AF. Li X, et al. Among authors: shaverdian n. Adv Radiat Oncol. 2023 Jun 7;9(1):101284. doi: 10.1016/j.adro.2023.101284. eCollection 2024 Jan. Adv Radiat Oncol. 2023. PMID: 38260213 Free PMC article.
Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-Small Cell Lung Cancer: A Phase 1 Dose-Escalation Trial.
Rimner A, Gelblum DY, Wu AJ, Shepherd AF, Mueller B, Zhang S, Cuaron J, Shaverdian N, Flynn J, Fiasconaro M, Zhang Z, von Reibnitz D, Li H, McKnight D, McCune M, Gelb E, Gomez DR, Simone CB 2nd, Deasy JO, Yorke ED, Ng KK, Chaft JE. Rimner A, et al. Among authors: shaverdian n. Int J Radiat Oncol Biol Phys. 2024 Jul 1;119(3):869-877. doi: 10.1016/j.ijrobp.2023.12.018. Epub 2023 Dec 26. Int J Radiat Oncol Biol Phys. 2024. PMID: 38154510 Clinical Trial.
Clinical outcomes of stereotactic body radiation therapy for malignant pleural mesothelioma.
Shin JY, Offin M, Simone CB 2nd, Zhang Z, Shepherd AF, Wu AJ, Shaverdian N, Gelblum DY, Gomez DR, Sauter JL, Ginsberg MS, Adusumilli PS, Rusch VW, Zauderer MG, Rimner A. Shin JY, et al. Among authors: shaverdian n. Radiother Oncol. 2024 Feb;191:110057. doi: 10.1016/j.radonc.2023.110057. Epub 2023 Dec 15. Radiother Oncol. 2024. PMID: 38104783
Standard-of-care systemic therapy with or without stereotactic body radiotherapy in patients with oligoprogressive breast cancer or non-small-cell lung cancer (Consolidative Use of Radiotherapy to Block [CURB] oligoprogression): an open-label, randomised, controlled, phase 2 study.
Tsai CJ, Yang JT, Shaverdian N, Patel J, Shepherd AF, Eng J, Guttmann D, Yeh R, Gelblum DY, Namakydoust A, Preeshagul I, Modi S, Seidman A, Traina T, Drullinsky P, Flynn J, Zhang Z, Rimner A, Gillespie EF, Gomez DR, Lee NY, Berger M, Robson ME, Reis-Filho JS, Riaz N, Rudin CM, Powell SN; CURB Study Group. Tsai CJ, et al. Among authors: shaverdian n. Lancet. 2024 Jan 13;403(10422):171-182. doi: 10.1016/S0140-6736(23)01857-3. Epub 2023 Dec 14. Lancet. 2024. PMID: 38104577 Clinical Trial.
88 results